NCT00195143View on ClinicalTrials.gov

Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

August 31, 2005

Conditions
Parkinson's Disease
Interventions
GENETIC

Surgical infusion of AAV-GAD into the subthalamic nucleus

Trial Locations (1)

11030

North Shore University Hospital, Manhasset

Sponsors

Lead Sponsor

Neurologix, Inc.
All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

North Shore University Hospital

OTHER

lead

Neurologix, Inc.

INDUSTRY